140 related articles for article (PubMed ID: 8620476)
1. Expression of P-glycoprotein, encoded by MDR 1 gene, a metabolically active efflux pump in murine mast cells.
Wein D; Gupta S
Cancer Lett; 1996 Mar; 101(2):241-6. PubMed ID: 8620476
[TBL] [Abstract][Full Text] [Related]
2. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Twentyman PR; Rhodes T; Rayner S
Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein efflux pump expression and activity in Calu-3 cells.
Hamilton KO; Backstrom G; Yazdanian MA; Audus KL
J Pharm Sci; 2001 May; 90(5):647-58. PubMed ID: 11288109
[TBL] [Abstract][Full Text] [Related]
4. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.
Aggarwal S; Tsuruo T; Gupta S
J Clin Immunol; 1997 Nov; 17(6):448-54. PubMed ID: 9418184
[TBL] [Abstract][Full Text] [Related]
5. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.
Egashira M; Kawamata N; Sugimoto K; Kaneko T; Oshimi K
Blood; 1999 Jan; 93(2):599-606. PubMed ID: 9885221
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MDR1 gene and P-glycoprotein in canine mast cell tumor cell lines.
Nakaichi M; Takeshita Y; Okuda M; Nakamoto Y; Itamoto K; Une S; Sasaki N; Kadosawa T; Takahashi T; Taura Y
J Vet Med Sci; 2007 Feb; 69(2):111-5. PubMed ID: 17339753
[TBL] [Abstract][Full Text] [Related]
8. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines.
Dey S; Patel J; Anand BS; Jain-Vakkalagadda B; Kaliki P; Pal D; Ganapathy V; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2909-18. PubMed ID: 12824231
[TBL] [Abstract][Full Text] [Related]
9. Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to determine transduction frequency and in vivo selection.
Hegewisch-Becker S; Hanania EG; Fu S; Körbling M; Deisseroth AB; Andreeff M
Br J Haematol; 1995 Aug; 90(4):876-83. PubMed ID: 7669666
[TBL] [Abstract][Full Text] [Related]
10. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
Sincock PM; Ashman LK
Leukemia; 1997 Nov; 11(11):1850-7. PubMed ID: 9369417
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene C4 secretion from normal murine mast cells by a probenecid-sensitive and multidrug resistance-associated protein-independent mechanism.
Nguyen T; Gupta S
J Immunol; 1997 May; 158(10):4916-20. PubMed ID: 9144509
[TBL] [Abstract][Full Text] [Related]
13. Decreased potency of MDR-modulators under serum conditions determined by a functional assay.
Ludescher C; Eisterer W; Hilbe W; Hofmann J; Thaler J
Br J Haematol; 1995 Nov; 91(3):652-7. PubMed ID: 8555069
[TBL] [Abstract][Full Text] [Related]
14. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
Jetté L; Murphy GF; Béliveau R
Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells.
Candussio L; Crivellato E; Rosati AM; Klugmann FB; Granzotto M; Giraldi T; Decorti G
Histochem J; 2001 May; 33(5):259-66. PubMed ID: 11563538
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of P-glycoprotein function using rhodamine 123.
Pétriz J; García-López J
Leukemia; 1997 Jul; 11(7):1124-30. PubMed ID: 9205001
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of verapamil, cyclosporin A and SDZ PSC 833 on rhodamine 123 transport and cell cycle in vinblastine-resistant Chinese hamster ovary cells overexpressing P-glycoprotein.
Pétriz J; Sánchez J; Bertrán J; García-López J
Anticancer Drugs; 1997 Oct; 8(9):869-75. PubMed ID: 9402314
[TBL] [Abstract][Full Text] [Related]
18. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation.
Piquette-Miller M; Pak A; Kim H; Anari R; Shahzamani A
Pharm Res; 1998 May; 15(5):706-11. PubMed ID: 9619778
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment.
Fardel O; Lecureur V; Corlu A; Guillouzo A
Biochem Pharmacol; 1996 Jun; 51(11):1427-36. PubMed ID: 8630083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
